期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

左炔诺孕酮宫内缓释系统对子宫内膜增生性疾病的治疗 被引量：11

下载PDF
导出
摘要 左炔诺孕酮宫内释放系统（LNG-IUS,商品名曼月乐）是一种有效的避孕药具,在应用的过程中,人们发现其还可用于治疗月经过多、子宫内膜异位症、子宫内膜增生性疾病等,本文仅就LNG-IUS治疗子宫内膜增生性疾病做以下综述。
作者 陈娜 刘欣燕
机构地区 北京协和医院妇产科
出处 《中国计划生育学杂志》 2012年第3期207-209,212,共4页 Chinese Journal of Family Planning
关键词 子宫内膜增生性疾病 左炔诺孕酮宫内缓释系统 治疗 左炔诺孕酮宫内释放系统 子宫内膜异位症 LNG-IUS 避孕药具 月经过多
分类号 R711.74 [医药卫生—妇产科学]
  • 相关文献

参考文献20

  • 1Kurman RJ,Kaminski PF,Norris HJ.The behavior of endometrial hyperplasia.A long term study of untreated hyperplasia in 170 pa-tients[J].Cancer,1985,56(2):403-412. 被引量：1
  • 2连利娟主编..林巧稚妇科肿瘤学[M].北京:人民卫生出版社,2006:986.
  • 3俞梅,甄璟然,陈蓉,郁琦.子宫内膜增生与癌变[J].中国处方药,2009(3):72-75. 被引量：5
  • 4Baak JPA,Wisse-Brekelmans ECM,Fleege JC,et al.Assessment of the risk of endometrial cancer in hyperplasia by means of morpho-logical and morphometrical features[J].Path Res Pract,1992,188(7):856-859. 被引量：1
  • 5Horn LC,Schnurrbusch U,Bilek K,et al.Risk of progression in complex and atypical endometrial hyperplasia:clinicopathologic anal-ysis in cases with and without progestogen treatment[J].Int J Gyne-col Cancer,2004,14(2):348-353. 被引量：1
  • 6Halmesmki K,Hurskainen R,Tiitinen A,et al.A randomized con-trolled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms[J].Hum Reprod,2004,19(2):378-382. 被引量：1
  • 7Chrisman C,Ribeiro P,Dalton VK.The lenvonorgestrel-releasing intrauterine system:an updated review of the contraceptive and non-contraceptive uses[J].Clin Obstet Gynecol,2007,50(4):886-897. 被引量：1
  • 8邓姗,郎景和.左炔诺孕酮宫内缓释系统的临床功用及相关基础研究[J].国外医学（妇产科学分册）,2004,31(5):285-288. 被引量：148
  • 9Volpe A,Botticelli A,Abrate M,et al.An intrauterine progesterone contraceptive system(52mg)used in pre-and peri-menopausal pa-tients with endometrial hyperplasia[J].Maturitas,1982,4(1):73-79. 被引量：1
  • 10Perino A,Quartararo P,Catinella E.Treatment of endometrial hy-perplasia with levonorgestrel releasing intrauterine devices[J].Acta Europaea Fertilitatis,1987,18(2):137-140. 被引量：1

二级参考文献31

  • 1Rutanen EM. Endometrial response to intrauterine release of levonorgestrel. Gynecol Forum, 1998, 3(1): 11-14. 被引量：1
  • 2Luukkainen T, Pakarinen P, Toivonen J. Progestin-releasing intrauterine system. Semi Reprod Med, 2001, 19(4): 355-363. 被引量：1
  • 3Zalel Y, Shulman A, Lidor A, et al. The local progestational efffect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow study. Hum Reprod, 2002, 17(11):2878-2880. 被引量：1
  • 4Guillebaud .I. The levnorgestrel intrauterine systemL: a clinical perspective from the UK. Ann N Y Acad Sci, 2003, 997(2): 185-193. 被引量：1
  • 5Backman T, Huhtala S, Luoto R, et al. Advance information improves improves user satisfaction with the levonorgestrel intrauterine system.Obstet Gynecol, 2002, 99(4): 608-613. 被引量：1
  • 6French R, Cowan F, Mansour D, et al. Hormonally impregnated intrauterine systems(IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev, 2001,(2):CD001776. 被引量：1
  • 7Backman T, Rauramo I, Huhtala S, et al. Pregancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol, 2004, 190(1):50-54. 被引量：1
  • 8Roy SN, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Saf, 2004, 27(2):75-90. 被引量：1
  • 9Xiao BL, Wu SC, Chong J, et al. Therapeutic effects of the lenonorgestrelrelesing intrauterina system in the treatment of idiopathic menorrhagia. Fertil Steril, 2003, 79(4):963-969. 被引量：1
  • 10Barrington JW, Arunkalivanan AS, Avdek-Fattah M. Compariso between the levonorgestrel intrauterine system (LNG-IUS)and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol, 2003, 108(1):72-74. 被引量：1

共引文献183

同被引文献81

  • 1邓姗,郎景和,冷金花,刘珠凤,孙大为,朱兰.曼月乐对子宫内膜异位症患者在位内膜增殖与凋亡的影响[J].生殖与避孕,2006,26(10):589-592. 被引量：114
  • 2谢增霞,谢梅青.子宫内膜增生症的治疗进展[J].现代妇产科进展,2006,15(11):870-872. 被引量：8
  • 3Orbo A, Ames M, Hancke C, et al. Treatment results of endo- metrial hyperplasia after prospeetive Dscore classification: a followup studycom paringeffect of LNG-IUD and oralpro- gestins versus observation only[J]. Gynecol Oncol,2008,111 : 68-73. 被引量：1
  • 4Gardner FJ, Konje JC, Bell SC, et al. Prevention of tamoxifen induced endometrialpolyps usingalevonorgestrel releasingintra- uterinesystem longterm followupof a randomised controltrial[J].GynecolOnco1,2009,114(3 ) :452-456. 被引量：1
  • 5金巧凤,赖爱鸾,张李松,杜强,冯向东.妇康片治疗子宫内膜单纯性增生的临床分析[J].首都医科大学学报,2007,28(5):652-654. 被引量：8
  • 6Mutter G, Zaino R, Baak J, et al. Benign endometrial hyperplasia se- quence and endometrial intraepithelial neoplasia [J]. Gynecol Pathol, 2007, 26 (2): 103-114. 被引量：1
  • 7Chrisman C, Ribeim P, Dalton VK. The lenvonorgestrel - releasing in- trauterine system: an updated review of the contraceptive and noneontra- ceptive uses [J]. Clin Obstet Gynecol, 2007, 50 (4): 886-897. 被引量：1
  • 8Higham J M, O'Brien P M S, Shaw R W. Assessment of menstrual blood loss using a pictorial chart[J]. Br J Obstetr Gynecol,1990,97(7): 734. 被引量：1
  • 9Orbo A, Ames M, Hancke C, et al. Treatment results of endometria 1 hyperplasia after prospective D-score classification:a follow-up study comparing effect of LNG-1UD and oral progestins versus observation only[J]. Gynecol Oncol,2008,111:68-73. 被引量：1
  • 10Hurskainen R, Salm iA, Paavonen J, et al. Expression of sexroid receptors and ki-67 in the endometria of menorrhagie women:effects of intrauterine levonorgestre [J]. Mol Hum Reprod,2000,6(11): 1013-1018. 被引量：1

引证文献11

二级引证文献64

中国计划生育学杂志
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部